- Home
- ANIP vs CDLR Comparison
ANIP vs CDLR Comparison
Compare ANIP & CDLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- CDLR
- Stock Information
- Founded
- ANIP 2001
- CDLR 2008
- Country
- ANIP United States
- CDLR Denmark
- Employees
- ANIP N/A
- CDLR N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- CDLR
- Sector
- ANIP Health Care
- CDLR
- Exchange
- ANIP Nasdaq
- CDLR Nasdaq
- Market Cap
- ANIP 2.0B
- CDLR 1.9B
- IPO Year
- ANIP N/A
- CDLR N/A
- Fundamental
- Price
- ANIP $95.75
- CDLR $21.50
- Analyst Decision
- ANIP Strong Buy
- CDLR
- Analyst Count
- ANIP 9
- CDLR 0
- Target Price
- ANIP $89.11
- CDLR N/A
- AVG Volume (30 Days)
- ANIP 394.4K
- CDLR 43.6K
- Earning Date
- ANIP 11-07-2025
- CDLR 08-26-2025
- Dividend Yield
- ANIP N/A
- CDLR N/A
- EPS Growth
- ANIP N/A
- CDLR N/A
- EPS
- ANIP N/A
- CDLR 0.78
- Revenue
- ANIP $747,399,000.00
- CDLR $546,159,718.00
- Revenue This Year
- ANIP $39.36
- CDLR $116.02
- Revenue Next Year
- ANIP $9.45
- CDLR $80.90
- P/E Ratio
- ANIP N/A
- CDLR $6.75
- Revenue Growth
- ANIP 38.68
- CDLR 277.89
- 52 Week Low
- ANIP $52.50
- CDLR $17.37
- 52 Week High
- ANIP $99.50
- CDLR $28.75
- Technical
- Relative Strength Index (RSI)
- ANIP 63.57
- CDLR 54.51
- Support Level
- ANIP $95.11
- CDLR $20.84
- Resistance Level
- ANIP $99.39
- CDLR $21.70
- Average True Range (ATR)
- ANIP 2.27
- CDLR 0.31
- MACD
- ANIP -0.89
- CDLR 0.02
- Stochastic Oscillator
- ANIP 50.13
- CDLR 87.73
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About CDLR Cadeler AS
Cadeler AS is an offshore wind farm vessel contractor. It is engaged in offshore wind farm construction, maintenance, and decommissioning and provides marine and engineering operations to the wind industry, focusing on safety and the environment. The company operates six offshore jack-up wind farm installation vessels. In addition to wind farm installation, these vessels can perform maintenance, construction, decommissioning, and other tasks within the offshore industry.